I Was Terrified of Finasteride. Then I Read the Actual Studies

The real numbers behind sexual side effects, nocebo fear, and why the internet makes hair loss treatment feel scarier than it really is.

By John Goss, Founder of Adegen

You have probably spent hours researching what hair loss treatment might do to you.

The forums. The Reddit threads. The YouTube videos from people who have never read a clinical trial in their lives but speak with absolute certainty about what finasteride did to them, or their friend, or someone they read about. The fear is everywhere. It is loud. And it has been very carefully engineered to keep you exactly where you are: paralyzed, not treating, and vulnerable to whatever “natural alternative” they are selling instead.

I know because I was exactly that person. I put off treatment for years because of what I read online. And during those years, my hair loss kept progressing while I kept researching. That is time and density that is hard to get back.

Here is what almost nobody showed me, and what almost nobody has shown you: what hair loss itself is doing to you. Right now. While you wait.

I want to put both sides of this on paper with actual numbers. Not anecdotes. Not forum posts. Peer-reviewed data on what treatment risks look like, and peer-reviewed data on what untreated hair loss does to the people living through it. Then I want you to look at those two columns side by side and make a decision based on real information.

Because that is what the people profiting from your fear are hiding from you. Not just that the side effect risk is small. That the cost of doing nothing is real, documented, and for most people, far worse.

The Actual Numbers on Finasteride and Dutasteride

This is where the fear lives. So let’s name the numbers precisely.

The largest independent long-term trial ever conducted on finasteride tracked 17,313 men for seven years at five times the standard hair loss dose. The drop in sexual function scores was 3.21 points at six months on a 100-point scale, shrinking to 2.11 points by year seven. The independent researchers concluded the effect “is minimal for most men and should not impact the decision to prescribe or take finasteride.”

For context: age alone drops that same score by 1.26 points per year. Finasteride at five times the standard hair loss dose produces less total impact over seven years than three years of simply getting older.

The absolute difference over placebo in the largest controlled hair loss trials is 1.7 percentage points.

1.7%.

That is the honest number. Not the relative risk figures that get quoted to make things sound dramatic. The absolute difference is the only number that actually tells you what you personally are likely to experience.

Side effects also decrease over time. By year five of treatment, reported rates fall to 0.3% or less.

An independent trial tracking 3,040 men on finasteride for four years found something worth knowing. By years two through four, sexual side effect rates were identical between the finasteride group and the placebo group: 7% in each, with no measurable difference in impotence or decreased libido. The body adjusts. Any initial difference largely resolves on its own.

The largest population study ever conducted on this question covered 2,213,600 patients across five independent studies published in European Urology Focus. Across more than two million men, researchers found no statistically significant association with depression and no statistically significant association with suicide. In men with no prior depression diagnosis, the hazard ratio for suicide was essentially 1.0, meaning no increased risk whatsoever compared to men not taking the medication.

For dutasteride, the picture is actually better. A meta-analysis of 15 randomized controlled trials found its sexual dysfunction risk was not statistically significant. Real-world surveillance of more than 700 men taking dutasteride for hair loss found decreased libido in just 1.3% and impotence in 1.0%. Those are very small numbers, consistent with what the controlled trials show.

One more thing worth understanding. A randomized trial published in the Journal of Sexual Medicine gave 120 men the exact same medication at the exact same dose. One group was told about potential sexual side effects. The other was not. The informed group reported sexual side effects at 43.6%. The uninformed group reported them at 15.3%. Same drug. Same dose. Being told about possible side effects nearly tripled the reporting rate.

The only difference was expectation. That should make you pause.

If you have spent significant time reading about finasteride side effects online before starting treatment, that exposure itself becomes a variable. The pharmacology of the drug is not the only thing acting on your experience.

There is also Post-Finasteride Syndrome, which comes up in nearly every online discussion about these medications. It is not recognized as a formal diagnosis by the FDA, the WHO, or any major regulatory agency. The early studies on it recruited exclusively from an advocacy website, introducing what researchers describe as severe selection bias. The largest meta-analysis covering 2.2 million patients found no statistically significant association with depression or suicide. This does not mean every person reporting symptoms is making them up. It means the evidence for it as a distinct syndrome does not hold up under controlled scientific scrutiny.

If those numbers still concern you, stay with me. Later in this article I am going to share exactly what I take personally that not only removes any fear around sexual side effects, it actually improves sexual health. It changed how I think about this entirely.

Those are the actual treatment numbers. Now here are the other ones.

What Hair Loss Actually Does to the People Living Through It

This is the data almost nobody in this space talks about. The fear-based content machine is entirely focused on what treatment might do. It has almost nothing to say about what untreated hair loss actually does to the people living through it. That silence is not an accident.

The psychological burden is documented, consistent across studies, and starts earlier than most people realize.

More than 25% of men with androgenetic alopecia describe their hair loss as extremely upsetting. Another 65% report modest to moderate emotional distress. For women, the psychological impact is consistently reported as even greater, with studies showing higher levels of emotional distress, self-consciousness, and quality of life impairment compared to male patients.

Meta-analyses published in JAMA Dermatology and Dermatology and Therapy consistently show that people with AGA have elevated symptoms of generalized anxiety, social anxiety, depression, and perceived stress compared to those without hair loss. These are elevated symptoms, not necessarily clinical diagnoses for most people. But elevated and persistent anxiety and depression symptoms, even below the clinical threshold, have a measurable impact on daily life. They affect how you walk into a room, how you perform at work, how you engage in relationships. They compound quietly over time.

Dermatology Life Quality Index scores for AGA patients average around 8.16 out of 30. That places hair loss in the moderate range of quality of life impairment, comparable to conditions like severe psoriasis and atopic dermatitis. These are not conditions anyone would dismiss as trivial.

Research on the social perception of hair loss, including work from the University of Pennsylvania, found that balding men are often rated lower on attractiveness and, in certain contexts, seen as less competent compared to men with full hair. Men with significant hair loss report higher rates of social withdrawal, avoidance of specific situations, and reduced confidence in dating and professional settings. The consistent themes across the research are loss of self-confidence, body image dissatisfaction, feeling older than their age, and a sense of helplessness about something they cannot control. These do not stay in the mirror. They follow you into every interaction.

For people who begin losing hair in their teens and twenties, the data is more severe. Earlier onset is consistently associated with greater psychological distress. The gap between expected appearance and reality is wider, and the social stakes at that life stage are higher. Job interviews. Dating. Social identity formation. All of it happening while the hair loss is progressing.

And the biology does not wait. By the time most people can see their hair loss with the naked eye, they have already lost up to 50% of their hair density. That is the clinical reality of how follicle miniaturization works. It progresses silently before it becomes visible. Every month of delay is a month of progression that early treatment could have slowed or stopped.

The Cost of Inaction, Side by Side

So if the risk of treatment is smaller than you have been led to believe, the next question is: what happens if you don’t treat at all?

This is the comparison the fear-based content will never show you. Because the moment you see it clearly, the argument falls apart.

The numbers are not close. They are not even in the same category.

The risk of treatment, for the vast majority of people, is a statistical abstraction. The documented cost of untreated hair loss is not an abstraction for the majority of people who report meaningful psychological impact. It is their daily reality.

I am not dismissing the experience of people who have had genuine side effects. Those experiences are real and deserve to be taken seriously. What I am saying is that the risk has been deliberately and systematically inflated, the cost of doing nothing has been deliberately and systematically ignored, and the people profiting from that imbalance are not on your side.

The Opportunity Cost

There is a concept in economics called opportunity cost. It refers to what you give up by choosing one path instead of another. In the context of hair loss, the opportunity cost of inaction is everything treatment could have preserved or restored during the months or years you spent deciding.

Hair loss does not pause while you are deciding. Every month you wait is a month of progression you cannot undo.

That is not fear-mongering. That is how the biology works. And the people selling you the idea that you should be terrified of treatment never mention it, because their entire business model depends on you not treating.

What I Actually Take, and Why

There is a daily medication called tadalafil, originally developed as a prostate medication, that works directly against the theoretical mechanism behind finasteride’s sexual side effects by increasing peripheral blood flow. Most people know it as Cialis. But what most people do not know is that at a low daily dose of 5mg, it carries a documented 34% reduction in mortality, 27% fewer heart attacks, 34% fewer strokes, and 32% lower rates of dementia, based on a 2024 study in the American Journal of Medicine covering data from more than 50 million men.

I take it every day as part of my own protocol. Not as a workaround. As an upgrade.

The theoretical mechanism behind finasteride’s sexual side effects involves reduced blood flow. Tadalafil works by increasing peripheral blood flow. These two things point in exactly opposite directions. So adding tadalafil to your protocol is not just a psychological reassurance. It is a physiological one. You are not just neutralizing a small theoretical risk. You are potentially coming out healthier than you started.

I cover the full picture in [The #1 Thing Men Fear Most When Considering Hair Loss Treatment], including the complete cardiovascular and prostate health data and exactly how I think about the protocol. It is worth reading alongside this one.

The Honest Summary

The risk of treatment is real but small. Documented, measurable, and for most people, either negligible or nonexistent. Side effects decrease with continued use. The largest population study ever conducted found no link to depression or suicide across more than two million patients. The fear has been inflated far beyond what the evidence supports.

The cost of doing nothing is also very real. Elevated symptoms of anxiety and depression. Moderate but meaningful quality of life impairment. A progressive biological process that does not pause while you are deciding.

When you put those two things next to each other with real numbers, the decision looks different than it did when you were only reading one side of it.

At some point, the research has to become a decision. You now have the actual numbers, on both sides, probably for the first time. Most people never get this far.

If you’re looking for the next step, our HairIQ 60-second Hair Assessment is the best place to start. It will tell you exactly which protocol is best suited for your specific situation.

Sources: Moinpour et al. (2007), Prostate Cancer Prevention Trial, Journal of the National Cancer Institute; Uleri et al. (2024), European Urology Focus; PLESS Trial; Kaufman et al. (1998), Merck Phase III trials; Mondaini et al. (2007), Journal of Sexual Medicine; Huang et al. (2021), JAMA Dermatology; Gupta & Sharma (2021), Dermatology and Therapy; Aukerman et al. (2022), psychological consequences of androgenetic alopecia; Mannes (2012), University of Pennsylvania, hair loss and social perception; Lee et al. (2019), Acta Dermato-Venereologica (dutasteride meta-analysis); Gubelin Harcha et al. (2014), JAAD; von Kuenssberg Jehle et al. (2024), American Journal of Medicine.